Company Profile

Lightspeed Genomics Inc (AKA: Solametrix)
Profile last edited on: 1/4/19      CAGE: 57UY9      UEI: KF2XCGN8BLR9

Business Identifier: Next-generation sequencing
Year Founded
2006
First Award
2009
Latest Award
2011
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2255 Martin Avenue Suite F
Santa Clara, CA 95050
   (408) 988-2700
   N/A
   www.lsgen.com
Location: Single
Congr. District: 17
County: Santa Clara

Public Profile

In 2013, Biosearch Technologies announced it has acquired a majority stake in LightSpeed Genomics, making the firm nolonger SBIR eligible. Formerly dba Solametrix, LightSpeed had been developing an optical detection technology called Synthetic Aperture Optics (SAO) for the life science and diagnostics market. In collbaoration with Biosearch a gene expression platform (StellarVision) was developed - optimized to work with Biosearch's Stellaris RNA FISH assays for detecting and quantifying single molecule RNA targets within individual cells. StellarVision could directly interrogate single cells, single molecules, and quantifies mRNA, lncRNA and viral RNA while imaging hundreds of cells with statistical significance in a single large field of view. LightSpeed's SAO technology enables massively parallelized optical detection combining coherent interferometric illumination and computational image reconstruction at ultra-high resolution. Anchored in work of the founders while at MIT, the company had developed optical detection technology for sequencing applications. In 2008 LightSpeed underwent a restructuring and secured new investors. While the firm's prototype sequencing platform successfully demonstrated SAO’s unique imaging capability, competitive saturation in the next-gen market reduced the commercial potential. The new technology - enabled by SAO optical methodology - took precednce, principal priority of LightSpeed's technical development program."

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2011 2 NIH $2,243,315
Project Title: Deep-Submicron Optical Detection For High-Density High-Throughput Dna

Key People / Management

  Jekwan Ryu -- President

  Bo Fishback -- Founder